The present study group has been committed to developing novel F-18-labeled radiotracers targeting the tumor-specific FAK, and we have conducted considerable research to seek molecules with high FAK affinity and the proper nature for diagnosis [10,11,12]. Here, PTK2 is linked to neoplasm.